Axel Ullrich

Axel Ullrich (born 19 October 1943) is a German cancer researcher and has been the director of the molecular biology department at the Max Planck Institute of Biochemistry in Martinsried, Germany since 1988. This department's research has primarily focused on signal transduction. Ullrich has received Hamdan Award for Medical Research Excellence, awarded by Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, Dubai, United Arab Emirates in 2008 and Ullrich and his team received the Wolf Prize in 2010. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Axel Ullrich', query time: 0.04s Refine Results
  1. 1
    Identification of Antiapoptotic Protein Kinases and Phosphatases by a Functional Genomics Approach

    Identification of Antiapoptotic Protein Kinases and Phosphatases by a Functional Genomics Approach by Reimar Abraham, Daniel Schubart, Axel Ullrich

    Published 2001-01-01
    Get full text
    Article
  2. 2
    Intravital Fluorescence Videomicroscopy to Study Tumor Angiogenesis and Microcirculation

    Intravital Fluorescence Videomicroscopy to Study Tumor Angiogenesis and Microcirculation by Peter Vajkoczy, Axel Ullrich, Michael D. Menger

    Published 2000-01-01
    Get full text
    Article
  3. 3
    The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis.

    The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis. by Toru Tateno, Sylvia L Asa, Lei Zheng, Thomas Mayr, Axel Ullrich, Shereen Ezzat

    Published 2011-12-01
    Get full text
    Article
  4. 4
    TaqMan®-based quantification of invasive cells in the chick embryo metastasis assay

    TaqMan®-based quantification of invasive cells in the chick embryo metastasis assay by Edward Htun van der Horst, Jörg H. Leupold, Rainer Schubbert, Axel Ullrich, Heike Allgayer

    Published 2004-12-01
    Get full text
    Article
  5. 5
    Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients

    Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients by Zhiguang Xiao, Silvia Gaertner, Alicia Morresi-Hauf, Rebecca Genzel, Thomas Duell, Axel Ullrich, Pjotr G. Knyazev

    Published 2017-05-01
    Get full text
    Article
  6. 6
    Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy

    Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy by Robert Torka, Kinga Pénzes, Simone Gusenbauer, Christine Baumann, István Szabadkai, Lászlȯ Őrfi, György Kéri, Axel Ullrich

    Published 2014-04-01
    Get full text
    Article
  7. 7
    PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.

    PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement. by Silvia Gärtner, Angela Gunesch, Tatiana Knyazeva, Petra Wolf, Bernhard Högel, Wolfgang Eiermann, Axel Ullrich, Pjotr Knyazev, Beyhan Ataseven

    Published 2014-01-01
    Get full text
    Article
  8. 8
    Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

    Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy by Peter Vajkoczy, Michael D. Menger, Brigitte Vollmar, Lothar Schilling, Peter Schmiedek, K. Peter Hirth, Axel Ullrich, T.Annie T. Fong

    Published 1999-04-01
    Get full text
    Article

Search Tools: